Death by a thousand cuts through kinase inhibitor combinations that maximize selectivity and enable rational multitargeting Journal Article


Authors: Outhwaite, I. R.; Singh, S.; Berger, B. T.; Knapp, S.; Chodera, J. D.; Seeliger, M. A.
Article Title: Death by a thousand cuts through kinase inhibitor combinations that maximize selectivity and enable rational multitargeting
Abstract: Kinase inhibitors are successful therapeutics in the treatment of cancers and autoimmune diseases and are useful tools in biomedical research. However, the high sequence and structural conservation of the catalytic kinase domain complicate the development of selective kinase inhibitors. Inhibition of off-target kinases makes it difficult to study the mechanism of inhibitors in biological systems. Current efforts focus on the development of inhibitors with improved selectivity. Here, we present an alternative solution to this problem by combining inhibitors with divergent off-target effects. We develop a multicompound-multitarget scoring (MMS) method that combines inhibitors to maximize target inhibition and to minimize off-target inhibition. Additionally, this framework enables optimization of inhibitor combinations for multiple on-targets. Using MMS with published kinase inhibitor datasets we determine potent inhibitor combinations for target kinases with better selectivity than the most selective single inhibitor and validate the predicted effect and selectivity of inhibitor combinations using in vitro and in cellulo techniques. MMS greatly enhances selectivity in rational multitargeting applications. The MMS framework is generalizable to other non-kinase biological targets where compound selectivity is a challenge and diverse compound libraries are available. © 2023, Outhwaite et al.
Keywords: antineoplastic agents; antineoplastic agent; neoplasm; neoplasms; computational biology; protein kinases; protein kinase inhibitor; protein kinase inhibitors; chemistry; biochemistry; catalytic domain; phosphotransferase; phosphotransferases; systems biology; enzyme active site; chemical biology; humans; human; polypharmacology; none; inhibitor combinations
Journal Title: eLife
Volume: 12
ISSN: 2050-084X
Publisher: eLife Sciences Publications Ltd.  
Date Published: 2023-01-01
Start Page: e86189
Language: English
DOI: 10.7554/eLife.86189
PUBMED: 38047771
PROVIDER: scopus
PMCID: PMC10769483
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. John Damon Chodera
    118 Chodera
  2. Sukrit Singh
    8 Singh